id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0579-0010,FDA,FDA-2013-N-0579,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2020-03-17T04:00:00Z,2020,3,2020-03-17T04:00:00Z,,2020-03-17T14:24:04Z,2020-05354,0,0,090000648444cc69
FDA-2013-N-0579-0009,FDA,FDA-2013-N-0579,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Biological
Products: Reporting of Biological Product Deviations and Human Cells,
Tissues, and Cellular and Tissue-Based Deviations in Manufacturing",Notice,30 Day Proposed Information Collection,2019-12-26T05:00:00Z,2019,12,2019-12-26T05:00:00Z,2020-01-28T04:59:59Z,2019-12-26T15:03:34Z,2019-27791,0,0,090000648424ffef
FDA-2013-N-0579-0007,FDA,FDA-2013-N-0579,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Biological Products: Reporting of Biological
Product Deviations and Human Cells, Tissues, and Cellular and TissueBased Deviations in Manufacturing",Notice,60 Day Proposed Information Collection,2019-07-31T04:00:00Z,2019,7,2019-07-31T04:00:00Z,2019-10-01T03:59:59Z,2019-12-02T19:43:49Z,2019-16243,0,0,0900006483dd472a
FDA-2013-N-0579-0006,FDA,FDA-2013-N-0579,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Publication,2017-05-25T04:00:00Z,2017,5,2017-05-25T04:00:00Z,,2017-05-25T15:25:47Z,2017-10736,0,0,0900006482611b62
FDA-2013-N-0579-0005,FDA,FDA-2013-N-0579,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Deviations in Manufacturing",Notice,30 Day Proposed Information Collection,2016-11-14T05:00:00Z,2016,11,2016-11-14T05:00:00Z,2016-12-15T04:59:59Z,2016-11-14T18:27:00Z,2016-27259,0,0,09000064823935bf
FDA-2013-N-0579-0003,FDA,FDA-2013-N-0579,"Agency Information Collection Activities; Proposed Collection; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Deviations in Manufacturing; Forms FDA 3486 and 3486A",Notice,60 Day Proposed Information Collection,2016-06-07T04:00:00Z,2016,6,2016-06-07T04:00:00Z,2016-08-09T03:59:59Z,2016-08-09T01:00:14Z,2016-13366,0,0,0900006482018b27
FDA-2013-N-0579-0002,FDA,FDA-2013-N-0579,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing; Forms FDA 3486 and 3486A",Notice,30 Day Proposed Information Collection,2013-12-04T05:00:00Z,2013,12,2013-12-04T05:00:00Z,2014-01-04T04:59:59Z,2013-12-30T02:01:45Z,2013-28990,0,0,09000064814a61ed
FDA-2013-N-0579-0001,FDA,FDA-2013-N-0579,"Agency Information Collection Activities; Proposed Collection; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing; Forms FDA 3486 and 3486A",Notice,General Notice,2013-06-05T04:00:00Z,2013,6,2013-06-05T04:00:00Z,2013-08-06T03:59:59Z,2013-06-05T14:27:01Z,2013-13279,0,0,090000648130b88c